"Perhaps that's why we have raised now - so we don't get squeezed in the negotiations?" DJ.
I think that's a great part of it. No Big Pharma JV negotiated with NEU's back against the fiscal wall. Big Pharma is not a monolithic singularity, but a somewhat oligopolistic group with a singular motivation: grow the sp. NEU is possibly buying time here so as to "entertain" competing offers, this being a good strategic move for management going forward with any deals.
They've done their sums/forward budgets, assessed their trial risks, and lined their ducks up well into next year. In essence, with success: "Hey! Big Pharma, bring it!" Without success, a lower sp more dilution from a CR to better fund (speed up?) all the other trials.
OV
"Perhaps that's why we have raised now - so we don't get...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.27 |
Change
0.650(3.15%) |
Mkt cap ! $2.718B | |||
| Open | High | Low | Value | Volume |
| $20.84 | $21.56 | $20.76 | $7.760M | 364.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1378 | $21.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.29 | 218 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |